Cytotoxic function of umbilical cord blood natural killer cells: Relevance to adoptive immunotherapy

Pediatric Hematology and Oncology

Volumn 28, Issue 8, 2011, Pages 640-646

  Lin, Syh Jae ^a   Kuo, Ming Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Adoptive immunotherapy; Cord blood; Interleukin 15; Natural killer cells

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CYCLOSPORIN A; GRANZYME B; HLA ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

CELL EXPANSION; CYTOTOXICITY; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; LEUKEMIA; LEUKEMIA RELAPSE; NATURAL KILLER CELL; PROTEIN EXPRESSION; REVIEW; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD NATURAL KILLER CELL;

CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; LEUKEMIA;

EID: 80054989209     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.613092     Document Type: Review

References (68)

1. Caligiuri MA. Human natural killer cells. Blood. 2008;112:461-469.
2. Orange JS, Ballas ZK.Natural killer cells in human health and disease. Clin Immunol. 2006;118:1-10. (Pubitemid 43012040)
3. Fehniger TA, Cai SF, Cao X, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26:798-811. (Pubitemid 46907665)
4. Diefenbach, A, Jensen ER, Jamieson AN, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature. 2001;413:165-171. (Pubitemid 32867877)
5. Pende D, Canton, C, Rivera P, et al. Role of NKG2D in tumor cell lysismediated by human NK cells: cooperationwith natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;31:1076-1086.
6. Moretta, A, Bottino C,Mingari MC, et al.What is a natural killer cell? Nat Immunol. 2002;3:6-8. (Pubitemid 34065607)
7. Lanier LL. NK cells receptors. Annu Rev Immunol. 1998;16:359-370.
8. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds. Dendritic cells and NK cells take centre stage. Nat Rev Immunol. 2005;5:112-124. (Pubitemid 40208901)
9. Robbins SH, Bessou G, Cornillon A, et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathol. 2007;3:e123.
10. Lopez MC, Palmer BE, Lawrence DA. Phenotypic differences between cord blood and adult peripheral blood. Cytom B Clin Cytom. 2008;76B:37-46.
11. Chin TW, Ank BJ,MurakamiD, et al. Cytotoxic studies in human newborns: lessened allogeneic cellinduced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cells. Cell Immunol. 1986;103:241-251. (Pubitemid 17224770)
12. Dalle JH,Menezes J,Wagner E, et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res. 2005;57:649-655. (Pubitemid 40578033)
13. Lin SJ, Yan DC. ICAM-1 (CD54) expression on T lymphocytes and natural killer cells from umbilical cord blood: regulation with interleukin-12 and interleukin-15. Cytokines Cell Mol Ther. 2000;6:161-164.
14. Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127-156. (Pubitemid 37549223)
15. Farag SS, VanDeusen JB, Fehniger TA, Caligiuri MA. Biology and clinical impact of human natural killer cells. Int J Hematol. 2003;78:7-17. (Pubitemid 36899896)
16. Nguyen QH, Roberts RL, Ank BJ, et al. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol. 1998;185:83-92. (Pubitemid 28280482)
17. Lin SJ, Yang MH, Chao HC, et al. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol. 2000;11:168-174.
18. Lin SJ, Cheng PJ, Huang YJ, Kuo ML. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidiumiodide based flow cytometry. Pediatr Allergy Immunol. 2004;15:79-85.
19. Webb BJ, Bochan MR, Montel A, et al. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 1994;159:246-261. (Pubitemid 24381053)
20. Qian JX, Lee SM, Suen Y, et al. Decreased interleukin-15 fromactivated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood. 1997;90:3106-3117. (Pubitemid 27444205)
21. Lin SJ,KuoML. Effect of cyclosporin-A on interleukin-15 activated umbilical cord blood natural killer cell function. Cytotherapy. 2008;10:397-405.
22. Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;9:713-725.
23. Orange JS, Harris KE, Andzelm MM, et al. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci USA. 2003;100:14151-14156. (Pubitemid 37499206)
24. Inoue H,MiyajiM, Kosugi A, et al. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase Cgamma following CD2 stimulation. Eur J Immunol. 2002;32:2188-2198. (Pubitemid 34965881)
25. Bryceson YT, March ME, Barber DF, et al. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med. 2005;202:1001-1012. (Pubitemid 41396899)
26. Mace EM,Monkley SJ, Critchley DR, Takei F. A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells. J Immunol. 2009;15:48-56.
27. Chen X, Trivedi PP, Ge B, et al. Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci USA. 2007;10:6329-6334. (Pubitemid 47186094)
28. Masilamani M, Nguyen C, Kabat J, et al. CD94/NKG2A Inhibits NK Cell Activation by disrupting the actin network at the immunological synapse. J Immunol. 2006;177:3590-3596. (Pubitemid 44359890)
29. Tanaka H, Kai S, Yamaguchi M, et al. Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol. 2003;71:29-38. (Pubitemid 36776049)
30. Engelmann I, Moeller U, Santamaria A, et al. Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population. Immunology. 2006;119:515-521. (Pubitemid 44722214)
31. Wang Y, Xu H, Zheng X, et al. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol. 2007;4:377-382.
32. Xing D, Ramsay AG, Gribben AG, et al. Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 ex vivo expansion. J Immunother. 2010;33:684-696.
33. Taga K, Yamauchi A, Kabashima K, et al. Target-induced death by apoptosis in human lymphokineactivated natural killer cells. Blood. 1996;87:2411-2418. (Pubitemid 26086884)
34. Azzoni L, Anegon I, Calabretta B, Perussia B. Ligand binding to Fc gamma R induces c-mycdependent apoptosis in IL-2-stimulated NK cells. J Immunol. 1995;154:491-499.
35. Ida H, Anderson P. Activation-induced NK cell death triggered by CD2 stimulation. Eur J Immunol. 1998;28:1292-1300. (Pubitemid 28156420)
36. Poggi A, Massaro AM, Negrini S, et al. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol. 2005;174:2653-2660. (Pubitemid 40279679)
37. BergM,LundqvistA,McCoyPJr, et al.Clinical-grade ex vivo- expandedhumannatural killer cells upregulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy. 2009;11:341-355.
38. Dominguez E,Madrigal JA, Layrisse Z, Cohen SB. Fetal natural killer cell function is suppressed. Immunology. 1998;94:109-114. (Pubitemid 28412795)
39. Giri JG, Anderson DM, Kumaki S, et al. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leuk. Biol. 1995;57:763-766.
40. Ranson T,VosshenrichCA,Corcuff E, et al. IL-15 is anessential mediator of peripheralNK-cellhomeostasis. Blood. 2003;101:4887-4893.
41. Taniguchi T, Miyazaki T, Minami Y, et al. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann N Y Acad Sci. 1995;766:235-244. (Pubitemid 26169103)
42. Lin JX, Migone TS, Tsang M, et al.The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 1995;2:331-339.
43. De Totero D, Meazza R, Capaia M, et al. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood. 2008;111:517-524.
44. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191:771-780.
45. Koka R, Burkett PR, Chien M, et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med. 2003;197:977-984. (Pubitemid 36523195)
46. Fehniger TA, Cai SF, Cao X, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26:798-811. (Pubitemid 46907665)
47. Huntington ND, Puthalakath H, Gunn P, et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa andMcl-1. Nat Immunol. 2007;8:856-863. (Pubitemid 47103041)
48. Nguyen QH, Roberts RL, Ank BJ, et al. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol. 1998;185:83-92. (Pubitemid 28280482)
49. Choi SS, Chabra VS, Nguyen QH, et al. Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol. 2004;11:879-888. (Pubitemid 39280593)
50. Munger W, Dejoy SQ, Jeyaseelan R, et al. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol. 1995;165:289-293.
51. Ruggeri L, Mancusi A, Burchielli E, et al. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis. 2008;40:84-90. (Pubitemid 350192306)
52. Clausen J, Wolf D, Petzer AL, et al. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigenidentical haematopoietic stem cell transplantation. Clin Exp Immunol. 2007;148:520-528. (Pubitemid 46701023)
53. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097-2100. (Pubitemid 34229476)
54. Willemze R, Rodrigues CA, LabopinM, et al; Eurocord-Netcord and Acute LeukaemiaWorking Party of the EBMT. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23:492-500.
55. Passweg JR, Stern M, Koehl U, et al. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant. 2005;35:637-643. (Pubitemid 40520947)
56. Fauriat C, Just-Landi S, Mallet F, et al. Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood. 2007;109:323-330. (Pubitemid 46053073)
57. Savani BN, Rezvani K, Mielke S, et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood. 2006;107:1688-1695. (Pubitemid 43242410)
58. Dunbar EM, BuzzeoMP, Levine JB, et al. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008;93:1852-1858.
59. Lundqvist A, McCoy JP, Samsel L, Childs R. Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49- mismatchedNKcells fromMHC-matched donors. Blood. 2007;109:3603-3606. (Pubitemid 46572556)
60. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105:3051-3057.
61. Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant. 2008;41:193-198. (Pubitemid 351188917)
62. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 1998;92:11-18. (Pubitemid 28303169)
63. MazurMA, Davis CC, Szabolcs P. Ex vivo expansion and Th1/Tc1maturation of umbilical cord blood T cells by CD3/CD28 costimulation. Biol Blood Marrow Transplant. 2008;14:1190-1196.
64. Nagamura-Inoue T,Mori Y, Yizhou Z, et al. Differential expansion of umbilical cord blood mononuclear cell-derived natural killer cells dependent on the dose of interleukin-15 with Flt3L. Exp Hematol. 2004;32:202-209. (Pubitemid 38177646)
65. Perez SA,Mahaira LG, Demirtzoglou FJ, et al. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival. Blood. 2005;106:158-166. (Pubitemid 40967188)
66. Robinson KL, Ayello J, Hughes R, et al. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7: potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp Hematol. 2002;30:245-251. (Pubitemid 34203731)
67. Condiotti R, Zakai YB, Barak V, Nagler A. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Exp Hematol. 2001;29:104-113. (Pubitemid 32054772)
68. Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood. 2005;106:376-383. (Pubitemid 40967217)